Specifically, IL12, IL2 and IFNG, all involved in Th1 mediated immune response [25,26], showed strong correlations in both ER+ and ER- breast cancer, while IL13 (involved in a Th2 immune response) was generally anti-correlated to these pathways. The gene discussed is IL13; the disease is breast carcinoma.